2022 Stronger - PH317 - Advancing Antimicrobial Stewardship for the Future - On Demand

This session features a panel of health care leaders who will share their experiences surrounding the benefits and importance of advanced antimicrobial stewardship programs.

After observing a surgical site infection (SSI) increase in certain orthopedic procedures, AtlantiCare Regional Medical Center’s Antimicrobial Stewardship Program modified its existing surgical prophylaxis protocol by adding gentamicin to reduce the postoperative infection rate — successfully reducing the rate of SSI occurrence. 

The centralized Antimicrobial and Diagnostic Advisement Program at Saint Luke’s Health System leads diagnostic stewardship efforts. The organization successfully navigated diagnostic challenges by hosting a diagnostic stewardship summit, informing other health systems how embracing diagnostics optimizes long-term fiscal and clinical gains.

Alta Hospitals established a multihospital, centralized antibiotic stewardship program (ASP) among five acute care and three subacute care community facilities. Within two years of its inception, this centralized ASP transformed the hospital facilities from having minimal ASP oversight to achieving the California Department of Public Health Antimicrobial Stewardship Program Honor Roll.

Join this session to hear great insights to help advance antimicrobial stewardship at your organization.

Target Audience

  • Pharmacists
  • Physicians
  • Other Healthcare Professionals

Learning Objectives

Identify the major pathogens associated with postoperative orthopedic surgeries.

Discuss the methods employed to ensure proper antibiotics are used for surgical prophylaxis in orthopedic procedures.

Outline strategies to engage multidisciplinary and leadership teams in the redeployment of a diagnostic testing application — leveraging the skills and knowledge of the antimicrobial stewardship program and microbiology department.

Identify the implementation, engagement and savings of a multi-facility, centralized, antibiotic stewardship program in a community health system.

Additional Information

AttachmentSize
PDF icon PH317.pdf920.42 KB
Course summary
Available credit: 
  • 0.75 ACPE Pharmacist
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 General CE – Attendance
  • 0.75 Interprofessional Continuing Education (IPCE)
Course opens: 
09/14/2022
Course expires: 
09/21/2023

Faculty

Joseph Reilly, PharmD, Pharmacist, AtlantiCare Regional Medical Center, Pomona, NJ

Nick Bennett, PharmD, BCIDP, Manager, Antimicrobial & Diagnostic Advisement Program, Saint Luke's Health System, Kansas City, MO

Sarah Boyd, MD, Medical Director, Antimicrobial & Diagnostic Advisement Program, Saint Luke's Health System, Kansas City, MO

Cindy (Mei Xian) Hsieh, PharmD, BCPS, BCIDP, Clinical Pharmacy Specialist – Infectious Diseases, Alta Hospitals System, Los Angeles, CA

Sehjan Bhura, PharmD, Chief Pharmacy Officer, Prospect Medical Holdings, Los Angeles, CA

Disclosure

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Disclosure Statements
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
 

Credit Types

Interprofessional Continuing Education (IPCE)

This activity was planned by, and for, the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

Pharmacists (CPE)

Vizient, Inc. designates this enduring material for a maximum of 0.75 contact hours for Pharmacists. 

Universal Activity Number: JA0006103-0000-22-090-H01-P

Physicians (CME)

Vizient, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals (General CE Credit)

Vizient, Inc. will award a maximum of 0.75 contact hours to all other healthcare professionals who successfully complete the activity. These individuals will receive a Certificate of Participation indicating the maximum credits available.

Many state licensing boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

Available Credit

  • 0.75 ACPE Pharmacist
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 General CE – Attendance
  • 0.75 Interprofessional Continuing Education (IPCE)
Please login or register to take this course.

 

Select the Obtain Credit button to access the activity.